Publication | Closed Access

Quantification of minimal residual disease levels by flow cytometry at time of transplant predicts outcome after myeloablative allogeneic transplantation in ALL

Transplant PredictsFlow CytometryTransplantationStem Cell TransplantationImmunologyHematologyGraft SurvivalMyeloablative Allogeneic TransplantationBlood TransplantationMedicineCell TransplantationGraft Rejection